IEFM
NRIX icon

IQ EQ Fund Management’s Nurix Therapeutics NRIX Stock Holding History

IQ EQ Fund Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.27M Buy
81,760
+16,215
+25% +$269K 0.1% 183
2025
Q4 		$1.24M Buy
65,545
+22,786
+53% +$327K 0.09% 188
2025
Q3 		$395K Buy
42,759
+16,353
+62% +$170K 0.03% 271
2025
Q2 		$301K Buy
26,406
+12,157
+85% +$131K 0.03% 274
2025
Q1 		$169K Buy
+14,249
New +$238K 0.02% 287

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

IQ EQ Fund Management's NRIX Position: Q1 2026 in Review

IQ EQ Fund Management increased its Nurix Therapeutics (NRIX) stake by 25% in Q1 2026, buying an estimated $269K and bringing the position to 81,760 shares worth $1.27M. The position accounts for 0.1% of the portfolio, ranked #183.

IQ EQ Fund Management first reported a position in NRIX in Q1 2025 and has held it in 5 quarters since. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • IQ EQ Fund Management held 81,760 shares of Nurix Therapeutics worth $1.27M as of Q1 2026.
  • IQ EQ Fund Management bought 16,215 Nurix Therapeutics shares in Q1 2026, an estimated $269K.
  • Nurix Therapeutics made up 0.1% of IQ EQ Fund Management's portfolio in Q1 2026, its #183 holding.
  • IQ EQ Fund Management first reported a position in Nurix Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.